Military Technology

Of course, pharmaceutical companies are not entirely without fault. Some pharmaceutical giants have deliberately raised drug prices, making these drugs too expensive for many patients to afford. This in itself is a kind of cruel exploitation. To some extent, these countries and regions adopt this method as a kind of confrontation of last resort, but this method of confrontation is more controversial.

To say that Wu Hao's intelligent bionic electronic prosthesis, medical intelligent mechanical exoskeleton, intelligent bionic electronic prosthetic eye, whether these medical equipment products are expensive or not, it is really hard to say.

Because compared to the price and performance of similar products at home and abroad, the prices of these products are really cheap. And it is still cheaper than similar products, and the performance is much higher, very much.

It is said that the majority of patients should be satisfied, but the fact is just the opposite. Many patients think that the price is still too expensive. There is no way that this group has a large number of people, and there are all kinds of people. In addition, this group itself is unable to work due to disability and other reasons, so the income level is generally low, so it is difficult to bear the excessive price.

Even though the price of these products is very cheap, there are still many people who can't afford it, and they still think the price is too expensive.

And for these patients, hundreds of thousands of medical devices are only one aspect, and there is also the cost of the entire treatment, which is also the bulk. Including related surgical transplant costs, conventional treatment costs, and follow-up rehabilitation training costs for these medical devices, etc., the sum of the scattered pieces is also a huge number, and it is not necessarily much cheaper than the price of medical devices.

This is also the reason why many of these disabled patients still cannot afford this cost.

So whether these medical devices can greatly reduce the cost and price is actually very difficult. Why I say this is because these medical devices involve personalization and customization.

We are different from person to person. In addition to individual character and soul, there are big differences in body height, skin color, blood type, etc. For example, the thickness and length of the limbs of different people are different, which also makes it possible for the intelligent bionic electronic prosthesis worn by the patient to be matched enough to match the proportion of the limbs, so these limbs need to be specially customized. , the price is of course very expensive.

In addition to the thickness and length of the limbs, there are also the proportions of the limbs. Some people may have longer fingers, some people may have shorter fingers, and people's skin color is not the same. Men's and women's hands are also very different. of. It is impossible to put a man's thick hand on a female patient, or a woman's delicate hand for a male patient, which is obviously not good.

These cannot be mass-produced, and can only be customized according to measurement data. The production process is complicated, and the price will rise.

Some people think about whether it can be carried out by centralized procurement. This method is actually feasible to a certain extent, but it is difficult. Because Wu Hao and the others set the cost price relatively low, there is not much room for concessions. Moreover, this thing itself is a high-end medical product, and it is basically impossible to join medical insurance. Also because of the high price, if the centralized procurement cannot reach the quantity, naturally there is no room for operation.

Of course, there are still some products that can be mass-produced, such as intelligent bionic electronic prosthetic eyes, which can be mass-produced. However, even if mass production is achieved, its price cannot be reduced much, because it is a high-end medical device product and the price is very high. Moreover, the related transplant operation is also very complicated, and the operation cost will be very expensive, so the overall price will be more expensive.

However, compared with the price, intelligent bionic electronic prosthetic eyes can help blind patients regain their sight. This is unmatched by any amount of money. Therefore, for these patients, as long as they can restore their health, no matter how much money they spend, it will be worth it. .

And Wu Hao and the others are now opening some product patent technologies to domestic and foreign medical device companies, not to say that they are free, but charged. Moreover, it is only part of the patented technology, and the core technology, including the core algorithm of the system, is still in their hands.

So even if these companies produce related smart medical device products, they are under their control. And through the channels of local medical device companies in these countries and regions, their products can also enter the markets of these countries and regions, which creates conditions for Haoyu Medical to become an internationally renowned and powerful medical enterprise brand.

Wu Hao and the others don't understand what other companies are doing. No, they see it very clearly. This is not a conspiracy, but a conspiracy. It is in front of everyone. For these pharmaceutical companies, as long as they make a profit, why not do it.

Back at the press conference, Wu Hao stood on the stage and waited for the cheers and applause from the audience to fade away, and then he continued to speak unhurriedly: "In addition to these external wearable intelligent bionic medical devices, we are still Huge breakthroughs have been made in the field of human intelligent bionic electronic organs. At present, we have developed an intelligent bionic artificial heart that can perfectly simulate all the functions of the human heart, as well as an intelligent bionic artificial kidney~www.readwn.com~ and the development process has always achieved A breakthrough smart bionic artificial liver.

Yes, we have carried out bionic research on the three most important organs and tissues in the human body, and have made great breakthroughs in key technologies.

Take the intelligent bionic artificial heart that we have already put into clinical trials as an example. At present, our Phase II clinical trials have basically come to an end. From Phase I clinical trials to Phase II clinical trials, we have successfully treated nearly 500 patients with heart failure. And patients with severe heart disease have completed intelligent bionic artificial heart transplants.

At present, among the nearly 500 patients, except for a very small number of patients, the postoperative recovery effect was poor due to other diseases caused by long-term heart disease, and a few died of complications. Most of the other patients recovered after surgery All are in excellent condition and have basically reached the level of full recovery.

After transplanting our intelligent bionic artificial heart, these patients can basically return to normal levels, and may even be better than normal people in some aspects.

Maybe ordinary people run for a while, and their heart beats very fast, which makes you have a very bad reaction. But on the side of the intelligent bionic artificial heart, these are not problems, so it can support the wearer to complete some more vigorous exercises.

Many of our patients have returned to normal life after surgery. They live, work and exercise just like normal people. Some of them even became famous local athletes, and some even started to try some extreme sports.

Let's get to know this ordinary and special group through a short video below. "

wap.

previous chapter

Back to Contents

next chapter

bookmark

If you like military technology, please collect it: () The update speed of military technology is the fastest on the entire network.